Emmessar Biotech&Nut - Quaterly Results

03 Feb 2024 Evaluate
Net sales declined -23.19%  to  Rs. 3.28 million from Rs. 4.27 millions.The Total Profit for the quarter ended December 2023 of Rs. 1.29 millions grew from Rs.-0.23 millionsThe company reported a good operating profit of 3.19 millions compared to 2.73 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 3.28 4.27 -23.19 4.80 7.03 -31.72 10.19 3.65 179.18
Other Income 5.25 4.45 17.98 15.09 13.18 14.49 17.51 19.19 -8.75
PBIDT 3.19 2.73 16.85 8.14 7.89 3.17 10.60 10.25 3.41
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 3.19 2.73 16.85 8.14 7.89 3.17 10.60 10.25 3.41
Depreciation 0.24 0.24 0.00 0.72 0.70 2.86 0.94 0.92 2.17
PBT 2.95 2.49 18.47 7.42 7.19 3.20 9.66 9.33 3.54
TAX 1.66 2.72 -38.97 3.62 4.12 -12.14 4.63 4.57 1.31
Deferred Tax 0.76 1.72 -55.81 1.46 2.12 -31.13 2.12 0.22 863.64
PAT 1.29 -0.23 -660.87 3.80 3.07 23.78 5.03 4.76 5.67
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 97.26 63.93 52.12 169.58 112.23 51.10 104.02 280.82 -62.96

Emmessar Biotech&Nut Share Price

41.49 1.61 (4.04%)
14-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1545.25
Dr. Reddys Lab 5861.00
Cipla 1356.95
Zydus Lifesciences 984.75
Lupin 1635.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.